Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recurrence in the Setting of Biochemical Failure Following Radical Prostatectomy
Latest Information Update: 08 Apr 2025
At a glance
- Drugs 64Cu SAR bisPSMA-Clarity Pharmaceuticals (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 08 Apr 2025 New trial record